

Cover Story
Chris Biggar, a 34-year-old from Ohio, had just landed his dream job working in R&D when he was diagnosed with stage 4 colon cancer.
Podcasts
Cancer Policy
In Brief


Clinical Roundup
Drugs & Targets


NCI Trials


NCI Trials for October 2025
The National Cancer Institute approved the following clinical research studies last month.
Trending Stories
- Class action complaint alleging GRAIL insider fraud resubmitted after dismissal
- Cancer centers adapt to life without site visits as NIH changes CCSG review
- How GLP-1RA drugs are reshaping patient physiology and the future of oncology
- Friends publishes three white papers ahead of annual meeting
Topics: Clinical trials on rare cancers, combination drug trials, multi-regional studies - Jonathan Licht named president, chief scientific officer at Van Andel Institute
- Revolution Medicines’ pancreatic cancer drug received a new priority voucher from FDA

















